134 related articles for article (PubMed ID: 12393648)
1. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia.
Chang CC; Lorek J; Sabath DE; Li Y; Chitambar CR; Logan B; Kampalath B; Cleveland RP
Blood; 2002 Dec; 100(13):4671-5. PubMed ID: 12393648
[TBL] [Abstract][Full Text] [Related]
2. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Ito M; Iida S; Inagaki H; Tsuboi K; Komatsu H; Yamaguchi M; Nakamura N; Suzuki R; Seto M; Nakamura S; Morishima Y; Ueda R
Jpn J Cancer Res; 2002 Jun; 93(6):685-94. PubMed ID: 12079517
[TBL] [Abstract][Full Text] [Related]
3. MUM1/IRF4 expression in the circulating compartment of chronic lymphocytic leukemia.
Craig F; Soma L; Melan M; Kant J; Swerdlow S
Leuk Lymphoma; 2008 Feb; 49(2):273-80. PubMed ID: 18231914
[TBL] [Abstract][Full Text] [Related]
4. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells.
Ocaña E; Delgado-Pérez L; Campos-Caro A; Muñóz J; Paz A; Franco R; Brieva JA
Haematologica; 2007 Mar; 92(3):349-56. PubMed ID: 17339184
[TBL] [Abstract][Full Text] [Related]
6. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
7. Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
Natkunam Y; Hsi ED; Aoun P; Zhao S; Elson P; Pohlman B; Naushad H; Bast M; Levy R; Lossos IS
Blood; 2007 Jan; 109(1):298-305. PubMed ID: 16954503
[TBL] [Abstract][Full Text] [Related]
8. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4.
Valsami S; Pappa V; Rontogianni D; Kontsioti F; Papageorgiou E; Dervenoulas J; Karmiris T; Papageorgiou S; Harhalakis N; Xiros N; Nikiforakis E; Economopoulos T
Haematologica; 2007 Oct; 92(10):1343-50. PubMed ID: 17768115
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-gamma (MIG) gene expression in B-cell malignancy.
Uranishi M; Iida S; Sanda T; Ishida T; Tajima E; Ito M; Komatsu H; Inagaki H; Ueda R
Leukemia; 2005 Aug; 19(8):1471-8. PubMed ID: 15959530
[TBL] [Abstract][Full Text] [Related]
10. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
12. Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.
Coupland SE; Hellmich M; Auw-Haedrich C; Lee WR; Anagnostopoulos I; Stein H
Br J Ophthalmol; 2005 Mar; 89(3):352-9. PubMed ID: 15722318
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
14. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin's disease.
Carbone A; Gloghini A; Aldinucci D; Gattei V; Dalla-Favera R; Gaidano G
Br J Haematol; 2002 May; 117(2):366-72. PubMed ID: 11972519
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells.
Falini B; Fizzotti M; Pucciarini A; Bigerna B; Marafioti T; Gambacorta M; Pacini R; Alunni C; Natali-Tanci L; Ugolini B; Sebastiani C; Cattoretti G; Pileri S; Dalla-Favera R; Stein H
Blood; 2000 Mar; 95(6):2084-92. PubMed ID: 10706878
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
17. Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia.
Allan JM; Sunter NJ; Bailey JR; Pettitt AR; Harris RJ; Pepper C; Fegan C; Hall AG; Deignan L; Bacon CM; Pointon JC; Houlston RS; Broderick P; Mainou-Fowler T; Jackson GH; Summerfield G; Evans PA; Strefford JC; Parker A; Oscier D; Pratt G; Allsup DJ
Leukemia; 2010 Apr; 24(4):877-81. PubMed ID: 20090783
[No Abstract] [Full Text] [Related]
18. IRF4/MUM1 expression is associated with poor survival outcomes in patients with peripheral T-cell lymphoma.
Heo MH; Park HY; Ko YH; Kim WS; Kim SJ
J Cancer; 2017; 8(6):1018-1024. PubMed ID: 28529614
[No Abstract] [Full Text] [Related]
19. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of multiple myeloma 1/interferon regulatory factor 4 (MUM1/IRF-4) in canine plasmacytoma: comparison with CD79a and CD20.
Ramos-Vara JA; Miller MA; Valli VE
Vet Pathol; 2007 Nov; 44(6):875-84. PubMed ID: 18039900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
